PACS vendor Lockheed Martin Western Development Laboratories MedicalImaging Systems appears to have a hammerlock on PACS contractsat hospitals operated by the Department of Veterans Affairs. TheHoffman Estates, IL, company last month announced that it
PACS vendor Lockheed Martin Western Development Laboratories MedicalImaging Systems appears to have a hammerlock on PACS contractsat hospitals operated by the Department of Veterans Affairs. TheHoffman Estates, IL, company last month announced that it hadwon three contracts worth a total of $4.6 million to install PACSat VA facilities.
Lockheed Martin has been a favorite of the VA since its earlierdays as Loral Medical Imaging Systems. Lockheed Martin is theprimary contractor on the Medical Diagnostic Imaging Support contract.The company also won $7.8 million in VA contracts last year.
Under last month's contracts, Lockheed Martin will installits Vantage medical image and information management systems atthree facilities. The projects involve:
** installing nine workstations at New Orleans VA Medical Center,a 470-bed hospital;
** connecting 14 VA hospitals in New York and New Jersey overa teleradiology wide area network; and
** installing seven workstations at Columbus VA Hospital inOhio.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.